ANNA MARIE BANTIGUE: Open Payments
NPI 1831315068 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 69 payments from 20 companies in 2025. Trend: 2023 $1,764 · 2024 $1,417 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $414 |
| ABBVIE INC. | 12 | $370 |
| Insulet Corporation | 5 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $106 |
| Lilly USA, LLC | 5 | $102 |
| Radius Health, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Mannkind Corporation | 4 | $65 |
| Amgen Inc. | 3 | $59 |
| Averitas Pharma Inc. | 2 | $51 |
Products named: Wegovy, JARDIANCE, SKYRIZI, UBRELVY, Omnipod, Ozempic, Tymlos, QULIPTA.
Industry payments across CA — which companies pay providers there.
